Cargando…

Can PCSK7 be A New Pharmaceutical Target?

Detalles Bibliográficos
Autor principal:	Kawashiri, Masa-aki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9444808/ https://www.ncbi.nlm.nih.gov/pubmed/35034921 http://dx.doi.org/10.5551/jat.ED188

Ejemplares similares

Your Foot Can Help Predict Your Cardiovascular Risk
por: Kawashiri, Masa-aki, et al.
Publicado: (2023)

Targeted Panel Sequencing will Boost Detection of Genetic Backgrounds of Familial Hypercholesterolemia in the World's Most Populous Country
por: Tada, Hayato, et al.
Publicado: (2020)

A Healthy Family of Familial Hypobetalipoproteinemia Caused by a Protein-truncating Variant in the PCSK9 Gene
por: Tada, Hayato, et al.
Publicado: (2020)

Genetic Variations, Triglycerides, and Atherosclerotic Disease
por: Tada, Hayato, et al.
Publicado: (2019)

Statin Intolerance and Suboptimal Statin Therapy
por: Tada, Hayato, et al.
Publicado: (2019)

The Effect of Diet on Cardiovascular Disease, Heart Disease, and Blood Vessels
por: Tada, Hayato, et al.
Publicado: (2022)

Triglycerides on the Rise!
por: Tada, Hayato, et al.
Publicado: (2021)

Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease
por: Tada, Hayato, et al.
Publicado: (2019)

Gene therapy for lipid disorders
por: Kawashiri, Masa-aki, et al.
Publicado: (2000)

PCSK9 inhibition in high-risk patients
por: Zijlstra, Laurien E., et al.
Publicado: (2019)

Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents
por: Tada, Hayato, et al.
Publicado: (2021)

The best pharmaceuticals for children—what can we do?
por: Li, Hao, et al.
Publicado: (2020)

PCSK9 Inhibition: Does Lipoprotein Size Matter?
por: Si‐Tayeb, Karim, et al.
Publicado: (2015)

Just Price for PCSK9 Inhibitors: No less, No More
por: Nasir, Khurram
Publicado: (2018)

Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice
por: Yamamoto, Tsuyoshi, et al.
Publicado: (2012)

Individualized Treatment for Patients With Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies
por: Tada, Hayato, et al.
Publicado: (2018)

Clinical Perspectives of Genetic Analyses on Dyslipidemia and Coronary Artery Disease
por: Tada, Hayato, et al.
Publicado: (2017)

New Paradigms in Pharmaceutical Development
por: Cacabelos, Ramón
Publicado: (2022)

PCSK9 and carbohydrate metabolism: A double-edged sword
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

New Advances in the Understanding of Proteases as Diagnostic and Pharmaceutical Targets in Homeostatic and Pathologic Conditions
por: Zamyatnin, Andrey A., et al.
Publicado: (2022)

PCSK9 Inhibitors: What Lies Beyond Monoclonal Antibodies?
por: EBioMedicine
Publicado: (2015)

Associations between questionnaires on lifestyle and atherosclerotic cardiovascular disease in a Japanese general population: A cross-sectional study
por: Tada, Hayato, et al.
Publicado: (2018)

Characterization of Autosomal Dominant Hypercholesterolemia Caused by PCSK9 Gain of Function Mutations and Its Specific Treatment With Alirocumab, a PCSK9 Monoclonal Antibody
por: Hopkins, Paul N., et al.
Publicado: (2015)

Ion Channels as a Potential Target in Pharmaceutical Designs
por: Wu, Sheng-Nan
Publicado: (2023)

Back to Basics: PCSK9 as a New Target for the LDL Receptor
por: Corral, Pablo
Publicado: (2014)

Metastasis Inhibition
por: Shibata, Masa-Aki, et al.
Publicado: (2023)

The discovery of PCSK9 inhibitors: A tale of creativity and multifaceted translational research
por: Elguindy, Ahmed, et al.
Publicado: (2013)

Case report: Unusual coexistence between familial hypercholesterolemia and familial hypobetalipoproteinemia
por: Sasaki, Kei, et al.
Publicado: (2022)

Traumatic Esophageal Injury Detected by Transthoracic Echocardiography
por: Oe, Kotaro, et al.
Publicado: (2017)

Prominent Tendon Xanthomas and Abdominal Aortic Aneurysm Associated with Cerebrotendinous Xanthomatosis Identified Using Whole Exome Sequencing
por: Tada, Hayato, et al.
Publicado: (2017)

Multi-vessel Coronary Vasospasm after Beta-blocker Administration
por: Tamura, Yudai, et al.
Publicado: (2018)

New Trends in Freeze-Drying of Pharmaceutical Products
por: Pisano, Roberto, et al.
Publicado: (2023)

Gene Therapy Targeting PCSK9
por: Katzmann, Julius L., et al.
Publicado: (2022)

Phage display for targeting PCSK9
por: Ferri, Nicola
Publicado: (2021)

New Avenues in Pharmaceutical Education
por: Udupa, N.
Publicado: (2011)

PCSK9 as a Target for Development of a New Generation of Hypolipidemic Drugs
por: Kuzmich, Nikolay, et al.
Publicado: (2022)

Children with Severe Hypercholesterolemia Caused by a Pathogenic Mutation in ABCG5
por: Tada, Hayato, et al.
Publicado: (2022)

Oral Fat Tolerance Test for Sitosterolemia and Familial Hypercholesterolemia: A Study Protocol
por: Nomura, Akihiro, et al.
Publicado: (2018)

Beneficial effect of ezetimibe-atorvastatin combination therapy in patients with a mutation in ABCG5 or ABCG8 gene
por: Tada, Hayato, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2rfur9v3o47pqubqfmbiiepabo